{"id":"W2792431643","doi":"10.1200/jco.2018.36.6_suppl.123","title":"Hypofractionated, dose escalation radiotherapy for high-risk prostate cancer: The primary endpoint of a group led phase III trial. (PCS5).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université du Québec à Chicoutimi; Hôpital Maisonneuve-Rosemont; Saint John Regional Hospital; Hôtel-Dieu de Québec; Hôpital Notre-Dame; Université Laval; Centre Hospitalier de l’Université de Montréal; McGill University; Cégep de Rimouski; Bausch Health (Canada); Centre Hospitalier Universitaire de Sherbrooke; Jewish General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Clinical endpoint; Randomized controlled trial; Prostate; Radiation therapy; Dose fractionation; Urology; Nuclear medicine; Adjuvant; Concomitant; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002525205,0.001469787,0.001289727,0.0004455923,0.0004719599,0.0008374777,0.001125115,0.001294106,0.004631947],"category_scores_gemma":[0.001296703,0.000354679,0.001677915,0.0006569001,0.001119622,0.0004126803,0.0004183743,0.002442093,0.0005703103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003062743,"about_ca_system_score_gemma":0.006674171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01765255,"about_ca_topic_score_gemma":0.05001046,"domain_scores_codex":[0.9992746,0.0003632366,0.00002607161,0.0001109426,0.0001032589,0.0001219293],"domain_scores_gemma":[0.9992781,0.00008821961,0.0001573747,0.00006585314,0.0000683818,0.0003421259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9350078,0.008576427,0.002454304,0.0007425782,0.001601307,0.00003630637,0.0001423223,0.002297697,0.003047297,0.0003793683,0.005092607,0.04062223],"study_design_scores_gemma":[0.9079399,0.08141844,0.006355843,0.00004506005,0.0005921843,0.0000386335,0.00002190043,0.0008196671,0.000517457,0.0002890714,0.001943948,0.00001805205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9661734,0.004279688,0.0014569,0.001397106,0.0003045772,0.01378314,0.0065757,0.0002086317,0.00582106],"genre_scores_gemma":[0.9729682,0.002050707,0.003934412,0.002290063,0.0002517999,0.0087077,0.005496119,0.00003570052,0.004265284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01765255,"threshold_uncertainty_score":0.03509957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1001937717959194,"score_gpt":0.5024123413044331,"score_spread":0.4022185695085137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}